Compass Therapeutics Inc.
2.46
0.46 (23.00%)
At close: Jan 15, 2025, 3:59 PM
2.36
-3.98%
After-hours Jan 15, 2025, 04:32 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -4.66 -14.38 -2.41 -8.87 -12.75 -11.57
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.33 2.91 1.42 6.55 -3.73 -5.23
P/FCF Ratio -4.88 -15.41 -9.39 -9.72 -13.75 -12.41
P/OCF Ratio -4.88 -15.5 -10.13 -9.76 -13.96 -13.15
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.02 0.03 0.23 -0.13 -0.17
Quick Ratio 19.73 12.05 13.84 4.97 2.67 6.96
Current Ratio 19.73 12.05 13.84 4.97 2.67 6.96
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -17.65 -221.3 -30.63 -27.73 -49.95
Return on Equity (ROE) -0.29 -0.2 -0.59 -0.74 0.29 0.45
Return on Assets (ROA) -0.27 -0.18 -0.54 -0.57 -1.14 -0.59
Return on Capital (ROIC) -0.34 -0.23 -0.57 -0.67 -1.66 -0.68
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a